Frances Rosario-Quinones1, Margret S Magid1, Jen Yau2, Amit Pawale3, Khanh Nguyen4. 1. Department of Pathology, Mount Sinai Hospital, New York, New York. 2. Division of Pediatric Cardiology, Mount Sinai Hospital, New York, New York. 3. Department of Cardiovascular Surgery, Mount Sinai Hospital, New York, New York. 4. Department of Cardiovascular Surgery, Mount Sinai Hospital, New York, New York. Electronic address: khanh.nguyen@mountsinai.org.
Abstract
BACKGROUND: Decellularized porcine small intestine submucosa (CorMatrix, Atlanta, GA) patches have been used in the repair of congenital heart malformations. Tissue reaction to the material may create hemodynamic dysfunction and necessitate explantation. We reviewed our series of congenital cardiac patients who had a reoperation after the implantation of CorMatrix patches. METHODS: Medical records of pediatric cardiac patient who received CorMatrix patches and those of patients who underwent reoperation were reviewed. Routine histologic sections of explanted CorMatrix specimens were examined. RESULTS: Of 25 patients who had received CorMatrix patches during cardiac operations at our institution, 6 patients had undergone reoperations. All patients had hemodynamically significant lesions at the site of the CorMatrix implantation. Explanted specimens were associated with an intense inflammatory reaction consisting of numerous eosinophils, histiocytes, and plasma cells, with accompanying granulation tissue and fibrosis. CONCLUSIONS: Reaction to implanted CorMatrix patches may cause hemodynamic dysfunction and produce an intense, predominantly eosinophilic inflammatory response with developing fibrosis. Although our report is limited to a small sample of congenital cardiac patients, one should take precautions in its use in pediatric cardiac patients, and long-term follow-up is warranted.
BACKGROUND: Decellularized porcine small intestine submucosa (CorMatrix, Atlanta, GA) patches have been used in the repair of congenital heart malformations. Tissue reaction to the material may create hemodynamic dysfunction and necessitate explantation. We reviewed our series of congenital cardiacpatients who had a reoperation after the implantation of CorMatrix patches. METHODS: Medical records of pediatric cardiac patient who received CorMatrix patches and those of patients who underwent reoperation were reviewed. Routine histologic sections of explanted CorMatrix specimens were examined. RESULTS: Of 25 patients who had received CorMatrix patches during cardiac operations at our institution, 6 patients had undergone reoperations. All patients had hemodynamically significant lesions at the site of the CorMatrix implantation. Explanted specimens were associated with an intense inflammatory reaction consisting of numerous eosinophils, histiocytes, and plasma cells, with accompanying granulation tissue and fibrosis. CONCLUSIONS: Reaction to implanted CorMatrix patches may cause hemodynamic dysfunction and produce an intense, predominantly eosinophilic inflammatory response with developing fibrosis. Although our report is limited to a small sample of congenital cardiacpatients, one should take precautions in its use in pediatric cardiac patients, and long-term follow-up is warranted.
Authors: Adeel Ashfaq; Amit Iyengar; Oh Jin Kwon; Mohammad S Soroya; Son Nguyen; Ryan Ou; Brian Reemtsen Journal: Pediatr Cardiol Date: 2017-07-15 Impact factor: 1.655
Authors: Ze-Wei Tao; Dillon K Jarrell; Andrew Robinson; Elizabeth M Cosgriff-Hernandez; Jeffrey G Jacot Journal: Adv Healthc Mater Date: 2021-10-08 Impact factor: 9.933
Authors: Yohei Ono; Diego Alejandro Dávalos Herrera; Jarret M Woodmass; Richard S Boorman; Gail M Thornton; Ian K Y Lo Journal: Orthop J Sports Med Date: 2016-12-15
Authors: Vishnu Vasanthan; Ali Fatehi Hassanabad; Simranjit Pattar; Paul Niklewski; Karl Wagner; Paul W M Fedak Journal: Front Bioeng Biotechnol Date: 2020-04-17